Default: Medicinal Research Reviews

ISSN: 0198-6325

Journal Home

Journal Guideline

Medicinal Research Reviews Q1 Unclaimed

John Wiley and Sons Inc. United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Medicinal Research Reviews is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 130. It has a price of 2750 €. It has an SJR impact factor of 2,868 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,868.

Medicinal Research Reviews focuses its scope in these topics and keywords: advances, targeting, receptor, binding, cancer, drug, diversify, discoverynew, discovery, developments, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

2750 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Medicinal Research Reviews

2,868

SJR Impact factor

130

H Index

105

Total Docs (Last Year)

162

Total Docs (3 years)

22297

Total Refs

1985

Total Cites (3 years)

157

Citable Docs (3 years)

12,11

Cites/Doc (2 years)

212,35

Ref/Doc

Aims and Scope


advances, targeting, receptor, binding, cancer, drug, diversify, discoverynew, discovery, developments, future, gastroprokinetic, heteroalicycles, highaffinity, identificationstrategies, improve, inde, lead, development, design, deliveryrecent, analogs, antagonistsmedicinal, antiemetic, antituberculosis, approaches, cell, chemical, chemistry, classes, cns, current, delivery,



Best articles by citations

Design of Hedgehog pathway inhibitors for cancer treatment

View more

Progress in antisense therapeutics

View more

Fas/FasL interaction: A novel immune therapy approach with immobilized biologicals

View more

Genetics, Genomics, and Drug Discovery

View more

Camptothecin and taxol: Discovery to clinic

View more

Repurposing approved drugs on the pathway to novel therapies

View more

Allosteric modulation of G protein-coupled receptors by amiloride and its derivatives. Perspectives for drug discovery?

View more

Competitive AMPA receptor antagonists

View more

Insights into the role of nitric oxide in inflammatory arthritis

View more

Small molecular anti-cytokine agents

View more

The Development of Delivery Agents that Facilitate the Oral Absorption of Macromolecular Drugs

View more

ATP site-directed competitive and irreversible inhibitors of protein kinases

View more
SHOW MORE ARTICLES

A systems approach to molecular structure, intermolecular recognition, and emergence-dissolvence in medicinal research

View more

Hepcidin and its therapeutic potential in neurodegenerative disorders

View more

Probes for the dopamine transporter: New leads toward a cocaine-abuse therapeutic?A focus on analogues of benztropine and rimcazole

View more

PROfusion?: Genetically Tagged Proteins for Functional Proteomics and Beyond

View more

ADP receptors on platelets and ADP-selective antiaggregating agents

View more

Transporters that translocate nucleosides and structural similar drugs: structural requirements for substrate recognition

View more

Applications of Lewis acids for the efficient syntheses of diltiazem, cephems, and taxoids

View more

Marine pyridoacridine alkaloids and synthetic analogues as antitumor agents

View more

Leptin: An annotated addendum

View more

Orexin supplementation in narcolepsy treatment: A review

View more

Structure-affinity relationships of adenosine A2B receptor ligands

View more

Emerging roles of allosteric modulators in the regulation of protein-protein interactions (PPIs): A new paradigm for PPI drug discovery

View more

Comments

No comments ... Be the first to comment!

FAQS